Tissue Regeneration

‫تعالى‬ ‫قال‬(‫الص‬ِ‫ب‬ ‫وا‬ُ‫ن‬‫ي‬ِ‫ع‬َ‫ت‬ْ‫س‬‫ا‬َ‫و‬َ‫ل‬‫الص‬َ‫و‬ ِ‫ر‬ْ‫ب‬ۚ ِ‫ة‬
َ‫ل‬َ‫ع‬ ‫َّل‬ِ‫إ‬ ٌ‫ة‬َ‫ير‬ِ‫ب‬َ‫ك‬َ‫ل‬ ‫ا‬َ‫ه‬‫ن‬ِ‫إ‬َ‫و‬ََ‫ي‬ِ‫ع‬ِِ‫ا‬ََْ‫ال‬ ‫ى‬)

Tissue engineering antecedents date form late
80s and beginning of the 90s. Tissue
engineering is an interdisciplinary field that
applies the principles of engineering and the
life sciences towards the development of
biological substitutes that restore, maintain, or
improve organ or tissue function [26].. .
Int. J. Mol. Sci. 2011, 12, 8217-8244
The interdisciplinarity of this field includes Biology,
Materials Science and Engineering as the main roots

The tissue engineering methodology follows a
similar generic scheme:
I) Cell recruitment: adult stem cells can be
isolated and after expanded and differentiated
in vitro. In order to improve tissue
regeneration, signal molecules ,such as
growth factors, are used in combination with cell
therapy.
Int. J. Mol. Sci. 2011, 12, 8217-8244

(ii) Biomaterial interaction. Recruited cells
are usually seeded in vitro onto artificial
biomaterial matrices, i.e., scaffolds. The
aim of these matrices is to give support to
the cells to develop its specific function
during the healing or regenerative
process. Cell-biomaterial interaction is critical
and the biomaterial should mimic the
extracellular space that it replaces
Int. J. Mol. Sci. 2011, 12, 8217-8244

(iii) Implantation. Seeded matrices,
performed ex vivo, are implanted in vivo for
tissue repairing. Here, biocompatibility
must be assured in order to prevent an
immunological rejection. Moreover, the
vascularization of the surrounded tissue
should occur within the artificial matrix.
Int. J. Mol. Sci. 2011, 12, 8217-8244

Structures and Functions of Normal
Living Cells

The cell is a unique biological living material
composed of different hierarchical structures at
different spatial levels. At the nanometer scale, we
can distinguish between four great classes of
macromolecules which build the living organisms
and the different structures of the cells, namely,
proteins, carbohydrates, lipids and nucleic acids.
Int. J. Mol. Sci. 2011, 12, 8217-8244

The anatomy of eukaryotic cells is divided into
plasma membrane, cytoplasm and nucleus.
Plasma membrane is a lipid bilayer structure
composed of intermembrane proteins,
cholesterol and glycoproteins. It is a barrier or
boundary of the cell which separates intracellular
structures and fluids with extracellular ones.
Int. J. Mol. Sci. 2011, 12,
8217-8244

The plasma membrane plays a dynamic role in
cellular activity and its main functions are
transport, enzymatic activity, signal
transduction, intercellular joining and cell-
cell recognition. Especially important is the
role that the plasma membrane plays in cell
attachment to the extracellular matrix (ECM)
or artificial biomaterial.
Int. J. Mol. Sci. 2011, 12, 8217-824

The nucleus is a double lipid bilayer (barrier) which
comprises the DNA and other important molecules.
The nucleus is considered the control center of the
cell and it regulates gene expression.
Int. J. Mol. Sci. 2011, 12, 8217-8244

Mechanical Aspects of Cell-
Biomaterial Interaction

The main mechanical component of the cell is
the cytoskeleton (CSK). It is a load-bearing
structure which transmits and sustains forces
exerted by the cell at different locations. CSK is
considered the cell skeleton or scaffolding of the
cell and is composed of microtubules, actin
filaments and intermediate filaments.
Int. J. Mol. Sci. 2011, 12, 8217-8244

CSK is involved in the process of cell attachment
to the ECM through the plasma membrane. there are
some other important cell junctions which are less
important for biomaterial interaction but are critical for
the formation of tissues, i.e., cell-cell adhesions. Cells
can attach to each other by the establishment of four
different unions: desmosome, tight junctions, gap
junction and microvilli.
Int. J. Mol. Sci. 2011, 12, 8217-8244

Mechanisms for Cell-ECM and
Artificial Substrate Interaction:
Plasma Membrane
ECM
Cell-ECM Interaction
Cell-Biomaterial Interaction on
Artificial Substrates

Plasma membrane:
It is selectively permeable to ions and
organic molecules, and controls the
movement of substances in and out of
cells [1].The main functions of the
membrane are transport, enzymatic
activity, signal transduction, intercellular
joining, cell-cell recognition and CSK-
ECM attachment.
Int. J. Mol. Sci. 2011, 12, 8217-8244

Plasma membrane architecture comprises an
arranged phospholipid bilayer being hydrophobic tail
regions are away from the surrounding polar fluid,
and the hydrophilic (water loving) head are in contact
with cytosolic and extracellular domains.
Other lipids contained in the membrane are
glycolipids and cholesterol, which has a steroid ring
structure, although the most abundant lipids are
phospholipids. Other important components of the
plasma membrane structure are integral proteins.Int. J. Mol. Sci. 2011, 12, 8217-82

These proteins are contained within the
transmembrane region and support the
selective movement of ions and small
molecules from one side of the
membrane to the other, sense a ligand on
one side of the membrane and transmit a
signal to the other side. The proteins that
move materials across the membrane can
be functionally divided into channels, pumps
and transporters [27].
Int. J. Mol. Sci. 2011, 12, 8217-8244

Among the different integral proteins, especially
important for cell adhesions are cadherins,
desmosomes and integrins. Cadherins and
desmosomes are specialized proteins for cell-cell
adhesions which ensure that forming tissues cells are
bound together. On the other hand, integrins are
adhesion-mediated proteins which link cells to
fibronectin or laminin in the extracellular matrix
[27].
Int. J. Mol. Sci. 2011, 12, 8217-8244

The ECM is the surrounding space between cells
which provides support and anchoring, i.e.,
adhesion.Other related functions of the ECM are to
capture growth factor proteins, being also essential in
biological processes such as growth and wound
healing. ECM plays also an important role in diseases
such as fibrosis or tumor invasion [1,28].
Int. J. Mol. Sci. 2011, 12, 8217-8244

The main constituents of the ECM are
proteoglycans, fibers and other molecules.
Proteoglycans are long chain carbohydrate
polymers negatively charged to attract water
molecules via osmosis in order to keep the ECM
hydrated. Furthermore, fibers include collagen and
elastin.

The rest of the proteins found in the ECM space
are fibronectin and laminin which are involved in the
process of cell-ECM adhesion. Specifically,
fibronectin connects cells with collagen fibers
in the ECM by binding them to cell membrane
integrins, causing a reorganization of the cell’s
cytoskeleton which facilitates cell movement
through the ECM.
Int. J. Mol. Sci. 2011, 12, 8217

In one hand, cells can attach the basal lamina
(lining outer surface of cell membrane) via
integrins to the intermediate filaments of the
CSK. On the other hand, cells are able to
anchor proteins of the basement membrane of
the ECM via integrins to the actin filaments of
the CSK.
Int. J. Mol. Sci. 2011, 12, 8217-8244

The latter kind of junction is referred to as a
hemidesmosome junction, whereas the former are
focal adhesions [4]. In this process, integrins and
related molecules migrate to the leading edge of
lamellipodia or filopodia protrusion (front of the cell)
which attach to the ECM [15].
Int. J. Mol. Sci. 2011, 12, 8217-8244

Cell-Biomaterial Interaction on
Artificial Substrates

In recent years, it has been evidenced that cell
interaction with artificially engineered substrates
and subsequent cell behavior is strongly
influenced by mechanical factors. In this sense, it
has been shown that cells exhibit very different
behaviors depending on the elasticity of the
substrate they are anchored to, or equivalently, on
the elasticity of the extracellular microenvironment
[6].
Int. J. Mol. Sci. 2011, 12, 8217-8244

A simple theory to explain these results, linked to the
observed behavior of cells on different substrates, may
be stated as follows. it is clear that cells on soft
substrates need be less contractile than on stiff
substrates and hence adhesions need not be as
strong [6].
Int. J. Mol. Sci. 2011, 12, 8217-8244

Engineered artificial constructs available for cell
adhesion must mimic the extracellular space it
replaces for a proper cell function and development.
Due to the great level of detail of the natural ECM,
exposed above, it makes this issue a challenging
problem in biofabrication.
Int. J. Mol. Sci. 2011, 12, 8217-8244

A natural way to approach this problem is
to use the natural ECM as a biologic
scaffold material [56] or a combination of
biofabricated scaffolds and the
incorporation of biological materials.
Int. J. Mol. Sci. 2011, 12, 8217-82

Cells Resources for Tissue Engineeri

Whether it is expected to start tissue
cellularization with fully differentiated cells, it
is better to obtain a cell biopsy from the
patient.

As another option, multipotent stem cells
(e.g., mesenchymal stromal cells and
endothelial progenitor cells; EPCs) can be
directed into desired differentiation. Lastly,
autologous induced pluripotent stem (iPS)
cells are a good alternative choice for the
source of required cell types.

One obvious requirement is that of
immune tolerance of the repaired
cells. It is essential to use patient-
specific autologous cells, in the
transplantation to avoid disease
transmission, life-long
immunosuppression, or the
possibility of rejection of
transplanted organ.

Induced Pluripotent Stem Cells
Induced pluripotent stem cells (iPS) are pluripotent
cell lines obtained from the ex vivo reprogramming
of fetal or adult somatic cells, like fibroblasts.
Reprogrammed cells are characterized by a high
plasticity, being able to differentiate in cells of
the three embryonal germ layers and thus
potentially having the capacity to differentiate in most of
the human body's cells (Takahashi et al., 2007; Yu et
al., 2007).

Foetal and Umbilical Cord Cells
Umbilical cord is collected at the time of birth; umbilical
cord blood cells (UCBMNCs) can be
isolated from the blood, while mesenchymal stem
cells are extracted from the Wharton's jelly.
Foetal-derived stem cells can be isolated from the
amniotic fluid and include both pluripotent stem cells
and more committed cells (Klemmt et al., 2011).

Biomaterials for tissue engine

Biomaterials can be defined as material devices
or implants used to repair/replace native body
tissues or as scaffolding materials adopted to
construct manmade tissues and organs [19]..
F.-M. Chen, X. Liu / Progress in Polymer
Science 53 (2016) 86–168

The basic role of biomaterials in
tissue engineering is to provide
temporary mechanical support
and mass transport to encourage
cell adhesion, proliferation, and
differentiation and to control the
size and shape of the
regenerated tissue [45].
Science 53 (2016) 86–168

Commonly, therapeutic biomaterials can be
classified into two main categories: (I)living
or once-living material of animal or human
origin;and (II) other materials, including
materials from vegetal sources and
synthetic materials and their composites
that are biocompatible and can be applied
for tissue regeneration

Ideally, a scaffold should serve
as a transient structure that, over
an extended period, will be
degraded or reabsorbed in a
controlled manner that is in
accordance with the regrowth rate
of new tissue [51,52].
Science 53 (2016) 86–168

Scaffolding biomaterials can be tailored to
mobilize and present biologically active
molecules, including cell adhesion peptides,
cell homing factors and numerous growth
/differentiation and mechanical signals; to
facilitate the recruitment of stem cells and
their subsequent differentiation into a large
number of daughter cells; and finally, to
direct new tissue formation and
integration [12,22,54–57].
Science 53 (2016) 86–168

tissue engineering
scaffolds seek to mimic
the natural ECM, at least
partially, and to create a
favorable
microenvironment to
support and induce tissue
formation [35]
Science 53 (2016) 86–168

Advantages of natural biomaterials
related to their bioactivity,
biocompatibility, tunable degradation
and mechanical kinetics and their
intrinsic structural resemblance of
native tissue ECM. [39].
Science 53 (2016) 86–168

Naturally derived biomaterials may
typically be divided into two groups:
protein-based biomaterials (e.g.,
collagen,silk fibroin, gelatin,
fibronectin, keratin, fibrin and egg
shell membrane) and
polysaccharide-based
biomaterials (e.g.,hyaluronan,
cellulose, glucose, alginate,
chondroitin, andchitin and its
derivative, chitosan).
Science 53 (2016) 86–168

Protein-based biomaterials are typically
obtained from animal and human
sources and include bioactive molecules
that mimic the extracellular environment,
whereas polysaccharide-based biomaterials
are mostly obtained from algae, as in the
case of agar and alginate, or from microbial
sources, as in the case of dextran and its
derivatives [40,41,52].

Another class of natural biomaterials
is termed decellularized tissue-
derived biomaterials, which are
created by the elimination of all
cellular and nuclear materials from
native tissues/organs, as in
decellularized dermis,heart valves,
blood vessels, small intestinal
submucosa(SIS) and liver, among
others.
Science 53 (2016) 86–168

Biomaterials can now include many
substances, such as engineered
constructs, therapeutic cells and
indeed, a number of living tissues or
organs used for transplantation
[21,23], that may generally not be
considered as biomaterials in the
past.
.-M. Chen, X. Liu / Progress in Polymer
Science 53 (2016) 86–168

Endeavors in the field of transplantation,
along side the shortage of tissue grafts and
donated organs available for use in
patients, have prompted the use of cells
and biomaterials for the creation of lab-
grown tissue/organ replacements that
mimic, at least to a large extent, the
complexity and functionality of a native
tissue [117].
Science 53 (2016) 86–168

Human MSCs can be obtained from
patient-derived tissue materials of
mesenchymal origin or tissues
derived there from, such as bone
marrow, blood, adipose tissue, and,
recently ,clinically discarded dental-
related tissues that have long been
considered to be of no use [118–122].
Science 53 (2016) 86–168

In the last case,a broad spectrum
of research has suggested that
dental pulp tissue, periodontal
ligaments and gingiva can be
envisaged as suitable and the
most accessible sources of stem
cells, whether in a healthy or
inflamed state [123–131].

Autologous tissue grafts,also called
autografts, are the gold standard with which
all other implantable biomaterials are
compared because these grafts maintain
large masses of living cells and possess all
of the properties required for new tissue
regrowth and structural reconstruction.
M. Chen, X. Liu / Progress in Polymer
Science 53 (2016) 86–168

Soft-tissue grafts
In dentistry, the management of gingival
recessions . In this case, a free gingival graft
(FGG) can be used either alone. or, most often,
adjuvanted with a coronally positioned flap
as an effective treatment for gingival recession.
As first described by Sullivan and Atkins (1968),
an FGG can be directly utilized to cover the
denuded root and restore the gingival margin to
its correct position [150)
Science 53 (2016) 86–168

Also, When placing dental implants
in partially edentulous areas, FGG,
whether alone or in combination with
another tissue augmentation
technique, is the best-documented and
most successful surgical procedure
for increasing the width of
keratinized mucosa and augmenting
the soft-tissue volume around implants
and in the esthetic zone [153].

Bone grafts:
Autologous bone grafts

To replace bone tissue with a
material that will eventually become
bone, surgeons’ first choice is to
use pieces of the patient’s own
bone. Autologous bone grafts are
the predominantly considered
osteoconductive materials for
bone replacement, with success
rates of well over 90% [166].
Science 53 (2016) 86–168

bone autografts from a patient’s own
body deliver no risk of immunological
rejection; possess complete
histocompatibility; and offer superior
osteogenic, osteoconductive
andosteoinductive performance
compared with other clinically
available grafting materials [167].

In oral and maxillofacial therapies,
historically, the best bone grafting
procedures have been particulate
cancellous bone/bone marrow autografts,
which can offer a rich source of bone and
marrow cells that have osteogenic
potential[185]. Histologic findings from case
reports substantiatethe potential for
autologous bone/bone marrow grafts to
support periodontal regeneration in humans
[186,187].

Allogenic tissue grafts:
1) Corneal and skin grafts
2) Composite tissue allotransplantation
3) Allogenic bone grafts
4) Human dentin matrixAs

The disadvantages of autologous
grafts are the limited amount of
available graft material and the
morbidity associated with their
harvest. This leading to using a
myriad of other grafting materials,
which can be classified into the
following categories:

:(i) allografts, also called allogenic or homologous gra
or homografts, which are composed of materials
acquiredfrom another individual of the same species.
(ii)xenografts, also known as heterografts or xenogen
grafts,which are materials acquired from another
species
(iii)alloplastic grafts or synthetic grafts, which are
artificial or manufactured materials that can be
subdivided based on their origin and chemical
composition [198].

Allogenic bone grafts
Allogenic bone grafts that are cadaveric in
origin and are available from commercial
vendors (e.g., bone banks) have been widely
used in reconstructive surgery. In this case,
the expense and trauma associated with
autograft harvesting, the quantity and size
limitations of grafts and donor site morbidity
are no longer concerns.
Science 53 (2016) 86–168

Although lacking osteogenic properties due to
the absence of living cells, allografts are in
possesion of both osteoconductive and weakly
osteoinductive abilities upon implantation
because they release bone morphogenetic
proteins (BMPs) that coax bone-forming
cells[223].
In addition to its advantages, such as its ready
availability in the required sizes and shapes and
its avoidance of the need to sacrifice host bone
structures for harvesting autografts.
Science 53 (2016) 86–168

The fundamental problems of this grafting
material are antigenicity and the potential
for infectious agent transmission,
minimized by recent strategies associated
with tissue processing, sterilization and
freezing. However, these procedures in
turn decrease graft properties with regard
to osteoinduction, osteoconduction and
mechanical strength,
Science 53 (2016) 86–168

The biological performance of bone
allografts may be ameliorated by the
incorporation of recombinant human
growth factors, autologous bone (or
exogenously cultured autologous
bone-forming cells), enamel matrix
derivative or various platelet-rich
preparations [176,239–241].
Science 53 (2016) 86–168

Human dentin matrix:
The use of human teeth removed for
orthodontic, impaction-related or irreversible
periodontic reasons as grafting materials
addresses several of the problems with the
bone grafting technique, such as the limited
availability of bone mass, the risk of donor
site infection and significant resorption of the
grafted bone, although there are still
concerns about the residual infective risks
[253].

Demineralized dentin matrix (DDM) from
bovine teeth was implanted into rabbit
knees with surgery-created full-thickness
articular cartilage defects. It was found that
the DDM led to active newbone formation
early in the postoperative period, indicating
that the DDM acted as a suitable
scaffolding material for osteochondral
regeneration [254].

Recently, it was demonstrated that
without causing an inflammatory
reaction or infection, allogenic DDM
significantly increased bone mass
and improved bone quality when it
was used as a bone grafting material
to treat surgically created bone
defects on the skull of rabbits [255].
Science 53 (2016) 86–168

Decellularized ECMs for
biomaterials

Recent advances in tissue/organ
decellularization offer acellular
human-derived biomaterials that
preserve the natural architecture
from the whole-organ level to the
microstructural scale and even
down to the nanoscale [287,475].
Science 53 (2016) 86–168

Even with a lack of living cellular
components, the decellularized ECM may
be regarded as a physiological depot for
various signaling molecules, which retain
their functionality, at least in part. Upon
application, these bioactive agents are
released and play their natural roles in cell
regulation,thus offering the specific ECM
the information necessary to conduct repair
and regeneration [102].
Science 53 (2016) 86–168

Specifically, human-derived
decellularized matrices can also be
considered biologically active scaffolds
capable of recruiting endogenous host
stem/progenitor cells and stimulating in
vivo cell proliferation and differentiation
toward the formation of a bio integrated
tissue [476].
Science 53 (2016) 86–168

The gentle removal of cells from human
tissue or organs can leave behind a
“footprint” within the ECM scaffold that
directs cell in growth and repopulation; the
biological components remaining in the
intact matrix may specifically enhance cell
activities such as adhesion, proliferation,
migration and differentiation in a way that
reflects the biological identity and functional
requisites of the original tissues [274].
Science 53 (2016) 86–168

Rationale and methods for decellularization
Decellularization is the process of stripping a donor
tissue or organ of its resident cells while maintaining
the native ultrastructure, ECM components and
chemical cues that are essential for cell preservation
and homeostasis in the remaining matrix template [475].
The removal of cells and a large proportion of the major
histocompatibility complex from the ECM templates
eliminates the inflammatory response, the foreign-body
reaction and the potential for immune rejection and thus
favors repopulation by new cells [274,479].

Unfortunately, no decellularization
methodology is absolutely effective in
removing all cellular components and
DNA materials from matrix constituents
(1 mg dry weight of matrix material
contains less than 50 ng of dsDNA), and
in terms of the biochemical and
structural properties of the resultant
product, all decellularization strategies
are highly variable in their results
[275,483].
Science 53 (2016) 86–168

Moreover, long periods of decellularizing, as
well as certain detergents,can adversely
influence GAG and collagen components
and then ECM antigenicity and/or integrity,
resulting in both disruption of the
construction and potential loss of the
surface composition and structure [484,485].
Science 53 (2016) 86–168

Biochemical methodologies for tissue/organ
decel-lularization include solvent extraction;
osmotic shock;acid/alkaline treatments; ionic and
nonionic detergent treatments; and enzymatic
digestion with lipase, proteases, DNase and
RNase. Recently, the pH of certain
decellularization solutions was found to influence
ECM retention (e.g., elastin, fibronectin and
laminin) and cell-removal efficacy of the resulting
product [489,490].
Science 53 (2016) 86–168

Direct force can also be used to aid in tissue decellularization.
Commonly, biochemical agents are employed in combination
with physical techniques to lyse cells, and the cell remnants
are then removed by rinsing [298].
Of course,any biochemical procedure applied to remove
cellular and nuclear materials may also slightly damage or
alter the native 3D architecture of the resulting ECM
template,and thus, during the decellularization process,
achieving a balance between chemical and physical
treatments is indispensable [274].

Undesirable layers, such as submucosa or muscle,are
first mechanically removed, and the resulting tissue is
briefly exposed to easily removed acids or detergents for
a relatively short time, followed by rinsing.
More extensive biochemical exposure and longer rinse
times are required for thicker tissue laminates, such as
dermis or cardiac muscle tissue (Fig. 14). In contrast, the
adjuvant use of lipid solvents such as alcohols is required
for amorphous tissues and organs, such as adipose
tissue, pancreas and brain(reviewed in Ref. [274]).
Science 53 (2016) 86–168

Not surprisingly, the utility of apoptosis as a
decellularization method goes beyond the
production of ECM materials with improved
performance.
The potential to specifically target the
cellular component of a tissue, the deliberate
activation of programmed cell death is
expected to better maintain the structural,
biochemical and/or biomechanical features of
the decellularized ECM [491].
Science 53 (2016) 86–168

Applications of decellularized ECMs
in tissue engineering:
Decellularized ECM can be directly
applied to recruit resident host cells
for endogenous tissue regeneration
based on the leveraging principles
of morphogenesis[22,55,477,498].

list of commercially available extracellular matrix (ECM)-
based products of human origin for tissue reinforcement or
replacement

Decellularized matrices may also be
processed to form particulates that
can be used either alone or in
combination with other biomaterials
to promote tissue repair,and
scaffolds may be prepared in many
forms, including sheets, powders
and hydrogels [535].
Science 53 (2016) 86–168

Whole-organ decellularization:
In light of the shortage of donor organs,
decellularized solid organs can be used to
create potentially functional organ
constructs in a short period of time, which
may perform organ-specific functions
following recellularization, and surgical
implantation and preliminary animal studies
have delivered encouraging outcomes for
this proof-of-concept [11,43,222,545]
Science 53 (2016) 86–168

Culturing cells within a decellularized
organ prior to implantation offers
scientists a high degree of control
over the fates of the residing cells, in
most cases, multiple cell types are
required to recellularize a complex
organ system (e.g., amixture of
cardiomyocytes, endothelial cells and
smoothmuscle cells is likely to be
necessary for heart recellularization)
[549].

A typical progressive protocol would begin with
treatment in a hypertonic or hypotonic solution,
followed by a mild zwitter ionic or nonionic
detergent. If needed, enzymatic treatment with
trypsin, either alone or in combination witha
chelating agent such as ethylene
diaminetetraacetic acid(EDTA) and ethylene glycol
tetraacetic acid (EGTA), can be used as an
adjuvant prior to the detergent treatment to aid in
disrupting the bonds between cell membranes and
the ECM
Science 53 (2016) 86–168

Finally, an ionic detergent such as
sodium dodecyl sulfate (SDS), Triton
X-100 or deoxy-cholate may be applied
in the decellularization protocol if the
prior treatments are still inadequate to
remove all of the cellular and nuclear
residues from the tissue ororgan of
interest [43,475,486].

Even when an organ ECM material is correctly
recellularized with sufficient cell numbers, it is
difficult to predict whether the engineered organ,
as a defective transplant, is going to work with
unpredictable fate or as a less-than-perfect
transplant but with “self-repairing” and
remodeling potential that will eventually restore
the impaired bodily function [11,222].

Preparations containing non-
expanded autologous stromal
cells :
1)Bone marrow concentrate
2)Stromal vascular fraction

Bone marrow concentrate
BMC contains a mixture of cell populations,
such as MSCs and HSCs, as well as other
substances, such as platelets and cytokines;
all can facilitate the regeneration of numerous
tissues as part of reconstructive surgery and
tissue engineering strategies [176].
Science 53 (2016) 86–168

Technically, the centrifugation of aspirated
bone marrow at 400 times gravity for10
min may completely separate the marrow
cells from the plasma to decrease the
volume of material injected, resulting in
the marrow product termed BMC. It has
been demonstrated that the osteogenic
potential of the cells can be well preserved
in a well-prepared BMC product [558].

Stromal vascular fraction
Human SVF cells can be easily
procured by centrifugation of
collagenase-digested adipose tissue
of human origin and are then ready for
biomedical application, without the
need for cell culture [556,557]. As such,
non-expanded SVFs provide an
alternative to cell products in regenerative
medicine.

It is also not clear whether the reported
positive outcome of SVF cell
administration was the result of local
immunosuppression, paracrine
expression of anti-apoptotic/angiogenic
factors, adipose cell differentiation, or a
combination of these or
otherunidentified effects [586].
F.-M. Chen, X. Liu / Progress in Polymer Science 53
(2016) 86–168

Formulations enriched with endogenous
growth factor:
Platelet-rich plasmaPRP
Platelet-rich fibrin
Platelet lysate

Platelet-rich plasma
PRP is a platelet concentrate in a small volume of plasma that is
typically developed from autologous blood[589,590
Upon activation, the platelets contained within a PRP
product release the contents of their granules, which
consist of a complex array of growth factors, cytokines and
chemokines, such as PDGFs(i.e., PDGF- , PDGF- and PDGF-
), TGF- (e.g., TGF- 1 and TGF- 2), insulin-like growth factor
(IGF), VEGF,platelet factor-4 (PF-4), platelet-derived
angiogenesis fac-tor (PDAF), IL-1, epidermal growth factor
(EGF), epithelialcell growth factor (ECGF), platelet-derived
endothelialgrowth factor (PDEGF), osteonectin, osteocalcin,
fibrinogen, fibronectin, vitronectin and thrombospondin-1 [592],

The interactions between these growth factors and their surface
receptors on responsive cells activate the intracellular signaling
pathways that enhance tissue regenerative processes, such as
cell proliferation and dif-ferentiation, matrix deposition, collagen
synthesis and osteoid production [595].
The common need for bovine plasma-derived thrombin, which
triggers platelet activation through the thrombin receptor, present
on the platelet surface, represents another limitation of current
protocols for obtaining a PRP product [599].
Recently, it has also been shown that PRP derived from bone
marrow aspirate promotes new cementum formation in rat
periodontal fenestration defect models [608]

Platelet-rich fibrin :
As a typical bioscaffold composed of
platelet concentrates, PRF consists of
a fibrin matrix polymerized in a tetra
molecular structure that contains all the
beneficial constituents of a blood sample
that are favorable to tissue
regeneration[42,614].

Recently, evidence has shown that well-prepared PRF can
gradually release a pool of endogenous growth factors for a
period lasting more than 20 days, implying a potentially
durable effect on wound repair [616].
Thus, autogenetic PRF may serve as a space-filling matrix
for implantable fillings or as a regenerative material. The
best characteristics of a PRF matrix for the clinical demands
of tissue engineering biomaterials include its autologous
nature, low cost, good manageability, functional flexibility
and absence of any allergic reaction or other adverse
effects in the patient [612].

Based on the inkjet printing technique ,for
example, PRF can be utilized as a
printable gel to generate specific cell
patterns in a 3D construct, offering a milieu
that mimics the highly hydrated state of a
native tissue, which renders this type of
construct a promising candidate for cell
delivery and tissue engineering [614].

In oral implantology, for example, the
handling and use of certain bone
grafting biomaterials and even bone
autografts are relatively challenging.
So that PRF acts as a biological glue
to hold matrix particles together, it is
possible to improve the handling and
adaptation of bone grafts by combining
them with scaffold-like PRF prior to
their transplantation into a defect site
[44,591,605].

Platelet lysate
platelet lysate (PL) and platelet-
released factors, have been
efficiently implemented into MSC
clinical manufaturing and
increasingly introduced into stem
cell therapyas a compelling
substitute for FBS [630–632].F.-M. Chen, X. Liu / Progress in Polymer
Science 53 (2016) 86–168

It is suggested that cell culture with
PL supplementation does not
change the expression of surface
markers on cultured cells compared
to that in cultures supplemented
with FBS [634]. Most importantly,
these cells retain their bio-logical
features, such as their growth and
differentiation potential favoring
target tissue regeneration [634,635]

In recent years, cumulative evidence has
strongly indicated that human PL-
supplemented media not only preserve cell
phenotypes and shorten culture time by
increasing the cells’ growth rate but also
maintain the cells’ multilineage differentiation
capacity and can give rise to
osteoblasts,chondrocytes, adipocytes,
neurons and astrocytes, among others
[630,634–638)

Design of ECM-mimicking
biomaterials: hydrogels

cells that grow in a natural niche
incorporating blood vessels
continuously receive nutrients and
oxygen, and their waste products,
includingCO2, are continuously
removed [26,286,287].

In contrast,when cells are grown in a stagnant
biomaterial-based scaffold without an ECM-
mimicking nano environment,nutrients and
oxygen are not transported into the cells, and
waste products are not removed from the cells.
Thus, the nutrient concentration decreases
and the concentration of waste products
increases until the artificial scaffold is
eventually noxious for cell viability and function
[45,114,293].

Ideally, the synthetic biomaterials used in tissue
engineering and cell delivery should create the same or
similar microenvironment for the seeded cells as that in
an ECM existing in vivo.
However, native ECMs have very intricate structures
and are composed of numerous types of proteins, many
of which remain unidentified thus far [37,280].
Therefore, using conventional physicochemical
methods, it is difficult to obtain a scaffold or substratum
that has the same composition and the complex
microstructure and architecture of an in vivo ECM[477].

Biomimetic hydrogels formed by self-
assembled biopolymer networks such as
silk, keratin elastin, resilinand periodate
oxidized alginate and gelatin display close
chemical, structural and mechanical
similarities with the native ECM and have
therefore been widely used as artificial cell
niches with tunable properties that favor
cellfunctions similar to the events occurring
in natural extra-cellular microenvironments
[64,317,387,469,673,674].

In addition, these hydrogels, which are
either derived from naturally occurring
molecules or are synthetic polymers that
recapitulate key motifs of biomolecules,
typically have a highly interconnected
porous network, good biological
compatibility and may be degraded by
proteolytic enzymes in the body, holding
great promise for various biomedical
applications [88,675].
F.-M. Chen, X. Liu / Progress in Polymer Science 53
(2016) 86–168

Cell-formed decellularized matrices:
self-assembly strategy

In particular, tissue and organ decellularization
is not suitable for the preparation of
decellularized matrices mimicking an ECM
[477,671].
The self-assembly strategy stems from the
capability of MSCs to secrete, deposit and
organize their own ECM. When these cells
are cultured in vitro, ECM proteins are
secreted from the cells and then deposited
beneath the cells.

The decellularization of these cell-formed matrices
enables the production of autologous constructs from
stem cells or from tissue-specific cells [243].
Recently, ECM derived from MSCs has been
demonstrated to maintain the multipotent potential
of MSCs during in vitro expansion and to rejuvenate
the cell functions of aging MSCs, indicating that cell-
formed ECM is an appropriate culture substrate to
improve the bioactivity of scaffolding biomaterials to
facilitate cell penetration [706].

In this regard, a “cell sheet” composed of living cells
and their secreted ECM may be created and grafted
onto the surface of a cell culture dish with the help of a
temperature-responsive,intelligent polymer. By altering
the temperature to below32◦C, a contiguous cell sheet
capable of maintaining intact ECM components and
cell–cell interactions canbe obtained [726].
Such strategies are relatively complicated and time-
consuming. To simplify the process,modified protocols
based on dexamethasone, vitamin C or osthole have
been developed to create cell sheets that do not
require special materials

The resulting sheets can be used for cell
transplantation, without the need for
synthetic biomaterials, which has already
paved the way to clinical therapeutics
and clinically relevant animal
experiments, such as studies on
esophageal ulcerations, periodontics and
type 1 diabetes, confirming the safety
and efficacy of the treatment [726–728].F.-M. Chen, X. Liu / Progress in Polymer Science 53
(2016) 86–168

However, in the self-assembly approach
to ECM biomaterials, it is difficult to
mimic the complicated native ECM-
like architectures. Because the ECM
secretion pattern of in vitro-cultured
cells is different from that of cells in
vivo, [477].

The disadvantages of naturally
derived biomaterials include
generally weak mechanical strength
and inconsistency in compositions
and properties, which are associated
with batch production due to their
origin in living beings[66].

To overcome these limitations, recent
advances in tissue engineering template
fabrication led to a paradigm shift
toward the development of biomimetic
scaffolds that incorporate ligands
imitating the native ECM. These
scaffolds are often utilized in vitro as
analogs of the natural ECM to facilitate
investigations of cell–ECM inter-play and
other intricate processes [67,68].

. Synthetic polymer biomateria

The use of synthetic polymers as matrices
and templates in bioengineering presents
several key advantages relative to naturally
derived polymers, offering attractive options
for the control of shape, architecture and
chemistry to generate reasonable
alternatives to or mimics of ECM[69,70].
Science 53 (2016) 86–168

The most widely used synthetic
polymers for tissue regeneration
are poly( -hydroxyacids), which
include polylactic acid (PLA),
polyglycolicacid (PGA) and their
copolymer, poly(lactic-co-
glycolicacid) (PLGA) [71,72].
Science 53 (2016) 86–168

These polymers’ nontoxic degradation
products (lactic acid and glycolic acid)
are generated via simple chemical
hydrolysis of the polymers and are
cleared away by normal metabolic
pathways [73]. Given the lack of
dependence on local enzyme
concentrations, chemical hydrolysis may
be more readily predicted and controlled
than enzymatic degradation in vivo
[63,71].

In addition, in situ-forming hydrogels
based on synthetic polymers can be
engineered to locally deliver a wide range
of bioactive agents in a controlled and
sustained manner to regulate stem cell
fates encapsulated within the 3D polymer
network, such as polyethylene glycol
(PEG) [78].
Science 53 (2016) 86–168

various synthesis techniques have been
developed and optimized to incorporate
biologically active domains into synthetic
polymer templates, thereby enabling the
production of biomimetic scaffolds with a
defined and tunable composition [82].
For example, coating synthetic polymeric
scaffolds with ceramic (calcium phosphate,
or CaP) is crucial for bone tissue engineering
applications [34,83].
Science 53 (2016) 86–168

In other cases, synthetic polymeric
scaffolds have been fabricated and
modified through the covalent
immobilization of ECM-derived moieties
to to promote cell attachment and to
enhance the directed differentiation of
progenitor cell populations [84].
Science 53 (2016) 86–168

Challenges in
biomaterial design

A single-component template does not meet
the requirements for a regenerative bio-
material matrix due to a lack of a controlled
degradation rate; a lack of desired
mechanical properties and bioactivity; and, a
lack of the desired cell–matrix interactions to
control gene expression, cytoskeletal
structure and dynamics [33,34]. A
combination of two or more types of
biomaterials into a medical device may
overcome several of these limitations.
Science 53 (2016) 86–168

Recently, 3D printing methods
have emerged to enable the
fabrication of scaffolds with defined
scaffold geometries while precisely
controlling the arrangement of cells
and bioactive nano materials
through-out the structure [98,99].
Science 53 (2016) 86–168

The disadvantages of naturally
derived biomaterials include generally
weak mechanical strength and
inconsistency in compositions and
properties, which are associated with
batch production due to their origin in
living beings[66].
Science 53 (2016) 86–168

ECM–stem cell interactions:
signposts in advanced
biomaterials

The coordinated interplay between
resident cells and their surrounding
natural or synthetic scaffolds, soluble
factors and other niche cells can define
a local mechanical and biochemical
micro environment that has been and still
is being studied and exploited to instruct
an orchestrated set of cell events and
reactions[297,664,734,735].

These cell population scan interpret
and interact with multiple input
signals and hence can be recruited to
areas of tissue damage to acquire active
biological functions, such as secreting
a cocktail of immune-regulating
signals or growth factors instead of, or
in addition to, directly participating in
regeneration of the tissue [22,277,498].

In the past three decades, 3D bioprinting has
been widely developed to directly or indirectly
fabricate 3D cell scaffolds or medical implants
for the field of regenerative medicine.It offers
very precise spatiotemporal control on
placement of cells, proteins, DNA, drugs,
growth factors, and other bioactivesubstances
to better guide tissue formation for patient-
specific therapy.[20,22,23]
Adv. Healthcare Mater. 2017, 6, 160

3D printing of bioactive scaffolds contains two
types of scaffold fabrication: acellular
functional scaffolds which incorporate
biological components, and cell-laden
constructs aiming to replicate native
analogues.[21,24] Both of them aim to
produce biocompatible, implantable
constructs for tissue/organ regeneration,
thus we refer to 3D printing in the context of
bioactive scaffold fabrication as “bioprinting”.

Therefore, medical imaging technology is an indispensable
tool to provide information on 3D structure and function at
the cellular, tissue, organ and organism levels, aiding the
design of a patient-specific construct.[20,25]
It commonly offers noninvasive imaging modality, including
computed tomography (CT) and magnetic resonance
imaging (MRI). Computer-aided design (CAD) and computer
aided manufacturing (CAM) tools and mathematical modeling
are also used to collect and digitize the complex tomographic
and architectural information for tissues.[25]

3D bioprinting shares three basic concepts with
ordinary 2D printing – desktop printer (3D printer),
print file (3D model file), ink (bioink consisting of
biomaterials, bioactive components and cells),
and paper (print platform).
Generally, the manufacturing activities can be
divided into three steps: pre-bioprinting
(modeling), bioprinting, and post-bioprinitng

Pre-bioprinting, also known as modeling, mainly includes 3D
imaging acquisition, digital 3D design and bioink/biomaterial
selection based on the type of 3D bioprinting model.[20]
Several imaging technologies, such as 3D scanner, CT, MRI
and others, are applied to collect and digitize the complex
tomographic and architectural information of tissues
Giesel et al.described and discussed the various methods of
3D imaging technology for 3D printing applications in
detail.[25] The desired structure of digital 3D models is
precisely created using CAD
software and stored as a stereolithography (stl) files. Bioink or
biomaterial selection depends on the specific bioprinter type
and the product properties required.

The 3D structure with patient-specific design is
then printed in layer-by-layer deposition modeling
process in the bioprinting phase. In this step, the
printer reads the stl file and deposits successive
layers of liquid, powder, or several other materials
to build the 3D model from a series of 2D cross-
sections. Several 3D printing techniques are
capable of using multiple nozzles
(multiplematerials), adjustable angles, and even
multiple printing combinations.

3D bioprinting for tissue engineering applications can be divided into
two forms, with and without incorporated living cells printed directly
into the constructs.
Cellular bioprinting techniques can directly deposit bioinks with viable cells
to forma 3D living structure. Based on the working strategies, they can
primarily be classified into three categories, droplet-based,extrusion-based
and laser-assisted bioprinting.[20,33] . Without the consideration of cell
viability or bioactive components, several 3D printing techniques with higher
temperatures, chemicals and otherharsh environments can be utilized to
manufacture implants.[34]
Finally, post-bioprinting, which involves the development of biomimetic
structures, mechanical supports and biological functionality, is an essential
step to develop mature tissues/ organs for living applications.[35,36]

Hard Biomaterials (Metals, Ceramics,
andThermoplastic Polymers) Common metals
such as stainless steel, titanium, and certain
alloys have been studied in 3D printing as
well, and some have progressed to clinical
trials.[68,69] However, limited 3D metal
printing techniques,metal corrosion and
ageing, and potential toxicity of metal ions are
serious considerations being further evaluated
for long term implantation.

Soft Biomaterials (Hydrogels)
Soft biomaterials mainly used in the cellular bioprinting techniques
are predominantly based on either naturally occurring polymers
and their derivatives (including alginate, gelatin, collagen,
chitosan, fibrin and
hyaluronic acid, often isolated from animal or human tissue) or
synthetic materials (polyethylene glycol (PEG), Pluronic F127
and their derivate copolymers, includes polyesters, polypeptides
or others).[21,65,79,81] The advantages of natural polymers are
their similarity to human ECM, and their inherent bioactivity,
however, they are limited by immunogenicity, weak mechanical
strengths and a lack of control in composition/molecular weight.
The advantage of synthetic polymers is that they can

be tailored with specific physical
properties in terms of tissue response
such as specific molecular weight,
chemical structure,composition and
functional group chemistry as well as
bioactive anchored sites (i.e., adhesion
motif or enzyme degradation sites) to suit
particular applications.[50]

Modern tissue engineering is not an easily accessible
approach to achieve regeneration in a clinical setting
[15].
In particular, several biological (e.g., a poor
understanding of underlying mechanisms), technical
(e.g., the large-scale expansion of stem cells) and
regulatory (e.g., cost and safety) hurdles relating to
the use of exogenously manipulated stem cells and
engineered constructs for human therapeutics have
yet to be overcome [16,17].
Science 53 (2016) 86–168

Tissue Regeneration

More Related Content

What's hot (20)

Similar to Tissue Regeneration (20)

More from Romissaa ali Esmail/ faculty of dentistry/Al-Azhar university (20)

Recently uploaded (20)

Tissue Regeneration

Editor's Notes